Original Sources · Chapter 16

FDA Revokes EUA for HCQ

Film time 00:45:51–00:47:42 · 1:51 long. Watch the chapter, then open each original source it uses, right here on the page.

Chapter 16 · 0:00 / 1:51 · film time 00:45:51

Sources in this chapter (9)

Click a timecode to jump the chapter player to the moment the source appears. Sources marked “Play the original here” load the original footage from its host only when you press play.

  1. 100:45:54

    FDA ends hydroxychloroquine authorization for coronavirus

    YouTube · 2020 · Video

    FDA ends HCQ emergency authorization

  2. 200:46:02

    Fmr. chief on the FDA’s decision to revoke emergency use of hydroxychloroquine

    YouTube · 2020 · Video

    Former FDA chief Gottlieb on EUA revocation / remdesivir

  3. 300:46:31

    Illumina | Sequencing and array-based solutions for genetic research

    illumina.com · 2023 · Other

    Illumina (Gottlieb board seat)

  4. 400:46:34

    Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

    illumina.com · 2023 · Other

    Illumina COVIDSeq EUA

  5. 500:46:34

    Coronavirus (COVID-19) Update: FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

    U.S. Food and Drug Administration · 2020 · Government/official doc

    FDA authorizes first NGS COVID test (Hahn quote)

  6. 600:47:09

    Illumina Acquires BlueBee, Data Analysis, Management

    Pubs - Bio-IT World · 2020 · News article

    Illumina acquires BlueBee

  7. 700:47:15

    Are Jeff Bezos and Bill Gates Wrong About Illumina?

    The Motley Fool · 2016 · News article

    Gates and Bezos invest in Illumina's Grail

  8. 800:47:15

    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against

    EIN News · 2023 · News article

    Investigation of Illumina/Grail

  9. 900:47:39

    Why Is Biopharma Paying 75% Of The FDA’s Drug Division Budget? Forbes

    23 Sep · 2022 · News article

    Industry pays 75% of FDA drug review budget

Chapter transcript
  1. 00:45:51 CDC,
  2. 00:45:51 and the WHO.
  3. 00:45:54 The Food and Drug Administration is ending its emergency authorization for the use of hydrochloroquine to treat COVID-19,
  4. 00:46:02 saying that the malaria drug carries too many risks without any apparent benefit.
  5. 00:46:07 There's been a number of studies now that have come out that haven't shown a benefit,
  6. 00:46:11 some have shown a harm,
  7. 00:46:12 as well as the information that it now could potentially interfere with the activity of remdesivir,
  8. 00:46:17 a directly acting antiviral that we know does work against coronavirus.
  9. 00:46:21 This accidental admission that hydroxychloroquine interferes with
  10. 00:46:25 a patient's ability to get sick enough to need remdesivir is
  11. 00:46:28 brought to you by former FDA Commissioner Scott Gottlieb.
  12. 00:46:31 Scott's a board member for a company called Illumina.
  13. 00:46:34 Illumina has been at the forefront of gene sequencing technology for companies like 23andMe.
  14. 00:46:39 On June 10th 2020,
  15. 00:46:40 less than a week before the FDA revoked emergency use authorization for hydroxychloroquine,
  16. 00:46:45 the FDA approved Illumina's application for COVID-Sec.
  17. 00:46:48 A gene sequencing test for COVID-19.
  18. 00:46:51 It not only tests you for COVID,
  19. 00:46:53 it also obtains your entire genetic code.
  20. 00:46:56 According to FDA Commissioner Stephen Hahn,
  21. 00:46:58 genetic sequencing information will help us monitor if and how the virus mutates,
  22. 00:47:03 which will be crucial to our efforts to continue to learn and fight this virus.
  23. 00:47:07 On June 17th 2020,
  24. 00:47:09 Illumina acquired a company called Bluebee.
  25. 00:47:11 Bluebee helps manage data like your genetic code.
  26. 00:47:15 Perhaps that's why Bill Gates and Jeff Bezos led a hundred million dollar round of funding for Illumina's spinoff called Grail in 2016.
  27. 00:47:22 Illumina repurchased Grail in 2021 and is now under investigation by the SEC for conduct and compensation of certain members of Illumina and Grail management.
  28. 00:47:33 Should we be trusting our genetic blueprint to these people?
  29. 00:47:38 According to Forbes,
  30. 00:47:39 the biopharmaceutical industry provides 75% of the FDA's drug review budget.

Full citations for the whole film stay in the Bibliography. Third-party footage belongs to its owners and is shown from its original host for reference. Spotted a missing or dead source? Press@EpidemicOfFraud.com

← All chapters